Visual Outcomes and Patient Satisfaction in Subjects With Stable Open-angle Glaucoma Undergoing Concurrent Minimally Invasive Glaucoma Surgery and IOL Implantation With an Extended-depth-of-focus IOL
Vold Vision P.L.L.C
Summary
This study is designed to determine how well patients with glaucoma can see following cataract surgery with a special type of lens called an extended-depth-of-focus (EDOF) lens. This lens is intended to reduced the patients need for glasses following cataract surgery. Patients will also undergo a minimally invasive type of glaucoma surgery using a special type of stent to reduce eye pressure, with the goal of better glaucoma control and the reduction in the need for medications to control eye pressure.
Description
To evaluate the range of vision and patient reported outcomes in subjects implanted with Clareon Vivity IOL undergoing concurrent MIGS with the Hydrus Microstent
Eligibility
- Age range
- 45+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Male or female subjects 45 years of age or older * A visually significant age-related cataract in both eyes * Diagnosis of mild OAG * VF characteristics consistent with glaucoma with mean deviation not worse than -6.00 dB and without fixation threatening scotoma AND/OR with nerve abnormalities consistent with glaucoma (rim notching, rim thinning, disc hemorrhage, nerve fiber layer loss) * Medicated IOP ≤25 mmHg on 1-3 hypotensive medications * Glaucoma must be judged as stable by investigator based on review of subject medical records * Stable VF at least 1 year…
Interventions
- DeviceVivity IOL
Cataract surgery with implantation of the Vivity IOL along with concurrent implantation of the Hydrus Microstent
Location
- Vold Vision P.L.L.C.Fayetteville, Arkansas